High Quality Content by WIKIPEDIA articles! Safinamide (EMD 1195686) is a candidate drug against Parkinson`s disease with multiple methods of action. In 2007, a Phase III clinical trial was started. It is scheduled to run until 2011. The drug will be marketed by Merck-Serono.